2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Keratosis, Actinic
29
Uterine Cervical Dysplasia
14
Carcinoma, Basal Cell
12
Melanoma
10
Glioma
6
Glioblastoma
6
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Neoplasm Metastasis
4
Keratosis
4
Condylomata Acuminata
4
Precancerous Conditions
3
Papillomavirus Infections
3
Hutchinson's Melanotic Freckle
3
Vulvar Neoplasms
2
Urinary Bladder Neoplasms
2
Squamous Intraepithelial Lesions
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasms
2
Hemangioma, Capillary
2
HIV Infections
2
Ependymoma
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Warts
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Vaginal Neoplasms
1
Stomach Neoplasms
1
Interventions
Surveys and Questionnaires
3
delta 24-sterol reductase
2
Urinary Diversion
2
Surgical Procedures, Operative
2
Propofol
2
daratumumab
1
Vascular Access Devices
1
Uterine Artery Embolization
1
Tranexamic Acid
1
Telemedicine
1
Pilot Projects
1
Patient Transfer
1
Parapsychology
1
Music Therapy
1
Midazolam
1
Mastectomy, Segmental
1
Lidocaine
1
Lead
1
Imiquimod
1
Ibuprofen
1
Fentanyl
1
Exercise
1
Drainage
1
Cystectomy
1
Control Groups
1
Colonoscopy
1
Bandages, Hydrocolloid
1
Anesthesia, Local
1
Ambulatory Care
1
Alfentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patient Satisfaction
×
Imiquimod
×
Clear all
NCT01861535
2021-04-14
PITVIN
Medical University of Graz
Phase 3
Completed
110 enrolled